Skip to main content
SpringerLink
Log in

Endoscopy in Inflammatory Bowel Disease: Western Perspective—Europe

  • Chapter
  • First Online:
Advances in Endoscopy in Inflammatory Bowel Disease

  • 1373 Accesses

Abstract

Endoscopy for IBD in Europe has in the last decade been driven by an agenda focussed on endoscopic quality and quality assurance. This has affected endoscopy in IBD practice in two specific areas; the use of chromoendoscopy for dysplasia detection, and endoscopic scoring systems of disease severity.

Chromoendoscopy studies for dysplasia detection have been positive; however, it was not recommended until 2010 when the British Society of Gastroenterology (BSG) led change with a new guideline, subsequently supported by the European Crohn’s and Colitis Organisation (ECCO) and European Society for Gastrointestinal Endoscopy (ESGE), which has become the standard of care in IBD in Europe. North America still lags behind Europe in this regard.

Validated scoring systems for colitis are key to ensure we speak an international “common language” between countries, but also to precisely convert research finding into clinical practice. Two validated scoring systems have become available recently, the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and the Ulcerative Colitis Colonoscopic Index of Severity (UCCIS). Regulatory agencies including the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are taking an active interest in scoring systems and outcome measures in clinical trials.

Quality and quality assurance are now embedded in IBD endoscopy in Europe by the use of chromoendoscopy and validated scoring systems. We need to evaluate whether this improves outcomes for patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370(14):1298–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bowles CJA, Leicester R, Romaya C, et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut. 2004;53(2):277–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Morris EJ, Rutter MD, Finan PJ, et al. Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service. Gut. 2015;64(8):1248–56.

    Article  PubMed  Google Scholar 

  4. Tada M, Katoh S, Kohli Y, et al. On the dye spraying method in colonofiberscopy. Endoscopy. 1977;8(2):70–4.

    Article  CAS  PubMed  Google Scholar 

  5. Togashi K, Konishi F, Ishizuka T, et al. Efficacy of magnifying endoscopy in the differential diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Dis Colon Rectum. 1999;42(12):1602–8.

    Article  CAS  PubMed  Google Scholar 

  6. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124(4):880–8.

    Article  PubMed  Google Scholar 

  7. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.

    Article  PubMed  Google Scholar 

  9. Elsadani NN, East JE, Walters JR. New 2010 British Society of Gastroenterology colitis surveillance guidelines: costs and surveillance intervals. Gut. 2011;60(2):282–3.

    Article  PubMed  Google Scholar 

  10. Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas: NICE guideline. 2014. 2–2-0014. Ref Type: Electronic Citation. http://www.nice.org.uk/nicemedia/live/13415/57930/57930.pdf.

  11. Kaminski MF, Hassan C, Bisschops R, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2014;46(5):435–49.

    Article  PubMed  Google Scholar 

  12. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.

    Article  PubMed  Google Scholar 

  13. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746–874.

    Article  PubMed  Google Scholar 

  14. Feagan BG, Sandborn WJ, D’Haens G, et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology. 2013;145(1):149–57.

    Article  CAS  PubMed  Google Scholar 

  15. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Cooney RM, Warren BF, Altman DG, et al. Outcome measurement in clinical trials for ulcerative colitis: towards standardisation. Trials. 2007;8:17.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Travis SP, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145(5):987–95.

    Article  PubMed  Google Scholar 

  18. Samuel S, Bruining DH, Loftus Jr EV, et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol. 2013;11(1):49–54.

    Article  PubMed  Google Scholar 

  19. Peyrin Biroulet L, Sandborn WJ, Sands B, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324–38.

    Article  CAS  PubMed  Google Scholar 

  20. Levesque, B. G., Loftus, E. V., Jr., and Panaccione, R.. Responsiveness of endoscopic indices in the evaluation of ulcerative colitis. J Crohns Colitis. 2014; P150, Ref Type: Abstract.

    Google Scholar 

  21. Gottlieb K, Travis SP, Sandborn WJ, et al. Clinical trial endoscopy and central reading of endoscopy endpoints for inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(10):2475–82.

    PubMed  Google Scholar 

  22. Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the ulcerative colitis endoscopic index of severity (UCEIS). Gut. 2012;61(4):535–42.

    Article  PubMed  Google Scholar 

  23. Corte C, Fernandopulle ANR, Cantuneau A, et al. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. J Crohns Colitis. 2015;9(5):376–81.

    Article  PubMed  Google Scholar 

  24. Travis SP, Schnell D, Feagan BG, et al. The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS] J Crohns Colitis. 2015;9(8):607–616.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Translational Gastroenterology Unit, Experimental Medicine Division, Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK

    James E. East & Simon P. L. Travis

Authors
  1. James E. East
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon P. L. Travis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James E. East .

Editor information

Editors and Affiliations

  1. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Insitiute Hospital, Minato-ku, Tokyo, Japan

    Toshifumi Hibi

  2. The Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

    Tadakazu Hisamatsu

  3. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Insitiute Hospital, Minato-ku, Tokyo, Japan

    Taku Kobayashi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Japan

About this chapter

Cite this chapter

East, J.E., Travis, S.P.L. (2018). Endoscopy in Inflammatory Bowel Disease: Western Perspective—Europe. In: Hibi, T., Hisamatsu, T., Kobayashi, T. (eds) Advances in Endoscopy in Inflammatory Bowel Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56018-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56018-0_29

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56016-6

  • Online ISBN: 978-4-431-56018-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation